Outcomes of Sequential Glaucoma Drainage Implants in Refractory Glaucoma.
Hu Wanda D, Moster Marlene R, Zheng Cindy X, Sabherwal Naryan, Pequignot Edward, Cvintal Victor, Ekici Feyzahan, Waisbourd Michael
AI Summary
Second glaucoma drainage implants effectively lower IOP and medication use in refractory glaucoma, with similar success regardless of implant type or location, offering a viable treatment option.
Abstract
Purpose
To describe the outcomes of eyes that have undergone a second glaucoma drainage implant (GDI) surgery.
Methods
A retrospective review of eyes that underwent a second GDI surgery from 2006 to 2013 was conducted. Primary outcome measures included intraocular pressure (IOP) reduction and success rates. Secondary outcome measures included glaucoma medication use, visual acuity, and number of reoperations. Success was defined as 6 ≤ IOP ≤ 21 with at least 20% IOP reduction, and no increase in the number of glaucoma medications from baseline at 3 months of follow-up or more.
Results
Sixty-five eyes (63 patients) had a mean follow-up of 22.4 ± 19.9 months. The most frequently placed second GDIs were an Ahmed FP7 (49%) or a Baerveldt 250 (26%) in the inferotemporal (46%) or inferonasal (35%) quadrant. At 3-year follow-up, IOP was reduced from 25.8 ± 7.7 to 17.4 ± 9.9 mm Hg (P = 0.004) and the number of glaucoma medications decreased from 3.6 ± 1.2 to 2.5 ± 1.4 (P = 0.01) compared with baseline. The median time to failure was 24.7 ± 5.8 months. There was no significant difference in failure rates for type of sequential GDI (P = 0.80) or plate location (P = 0.34). There was no significant difference in visual acuity between baseline and 3-year follow-up (P = 1.0). The most common postoperative complication was corneal edema (n = 9, 14%).
Conclusions
Most eyes undergoing a second GDI achieve adequate IOP control with fewer antiglaucoma medications. Failure rates were similar regardless of quadrant selection or GDI type.
MeSH Terms
Shields Classification
Key Concepts5
In a retrospective review of 65 eyes (63 patients) that underwent a second glaucoma drainage implant (GDI) surgery from 2006 to 2013, the intraocular pressure (IOP) was reduced from 25.8 ± 7.7 to 17.4 ± 9.9 mm Hg (P = 0.004) at 3-year follow-up compared with baseline.
In a retrospective review of 65 eyes (63 patients) that underwent a second glaucoma drainage implant (GDI) surgery from 2006 to 2013, the number of glaucoma medications decreased from 3.6 ± 1.2 to 2.5 ± 1.4 (P = 0.01) at 3-year follow-up compared with baseline.
In a retrospective review of 65 eyes (63 patients) that underwent a second glaucoma drainage implant (GDI) surgery from 2006 to 2013, the median time to failure was 24.7 ± 5.8 months.
In a retrospective review of 65 eyes (63 patients) that underwent a second glaucoma drainage implant (GDI) surgery from 2006 to 2013, there was no significant difference in failure rates for type of sequential GDI (P = 0.80) or plate location (P = 0.34).
In a retrospective review of 65 eyes (63 patients) that underwent a second glaucoma drainage implant (GDI) surgery from 2006 to 2013, the most common postoperative complication was corneal edema (n = 9, 14%).
Related Articles5
Midterm Survival Results of Preserflo in a Real-World Setting.
Cohort StudyComparing Treatment Outcomes from the Tube Versus Trabeculectomy and Primary Tube Versus Trabeculectomy Studies.
Randomized Controlled TrialThree-year outcome of sulcus fixation of Baerveldt glaucoma implant surgery.
Observational StudyThe Effect of Tube Ligature on the Safety and Efficacy of Ahmed Glaucoma Valve Surgery.
Case-Control StudySurgical Outcomes of Superotemporal Versus Inferonasal Placement of Aurolab Aqueous Drainage Implant in Refractory Pediatric Glaucoma.
Case SeriesIs this article assigned to the wrong chapter(s)? Let us know.